Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Dr. Cunningham discusses new data from ACC 2025 showing that finerenone lowers NT-proBNP and improves outcomes in patients with HFmrEF/HFpEF.
Media formats available
Completing the pre-test is required to access this content.
Pre-Survey
Completing the pre-survey is required to access this content.